Federal award
MOLEKULE GROUP, INC.
W912HQ20C0068
Contract
Obligated and Ceiling
- Obligated (net)
- $1,107,418.00
- Ceiling (potential value, not spending)
- $1,107,418.00
- Current value
- $1,107,418.00
- Gross positive obligations
- $1,107,418.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- MOLEKULE GROUP, INC. · DS5ST5JMBP39
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MOLEKULE GROUP, INC. · DS5ST5JMBP39
- Awarding agency
- Department of War · sub-agency 2100 · office W912HQ
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AH91 · R&D- ENVIRONMENTAL PROTECTION: OTHER (BASIC RESEARCH)
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- W912HQ20C0068
- Award type code
- D
- Actions
- 9 · Sep 17, 2020 to Aug 26, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Aug 26, 2025 | FY2025 | P00008 | B | $0.00 | — |
| Oct 4, 2024 | FY2025 | P00007 | B | $0.00 | — |
| Mar 14, 2024 | FY2024 | P00006 | B | $0.00 | — |
| Feb 7, 2024 | FY2024 | P00005 | B | $249,375.00 | — |
| Apr 6, 2023 | FY2023 | P00004 | B | $0.00 | — |
| Sep 26, 2022 | FY2022 | P00003 | C | $203,281.00 | — |
| Aug 22, 2022 | FY2022 | P00002 | B | $59,600.00 | — |
| Jun 14, 2022 | FY2022 | P00001 | C | $214,599.00 | — |
| Sep 17, 2020 | FY2020 | 0 | — | $380,563.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.